Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin

BACKGROUND: Not enough data are available about the effectiveness of consensus interferon (CIFN) among HCV genotype 3 patients who failed to respond to pegylated interferon and ribavirin. OBJECTIVES: We aimed to assess the efficacy and safety of CIFN and ribavirin in non-responders and relapsers to...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Abbas, Zaigham, Tayyab, Ghiasun Nabi, Qureshi, Mustafa, Memon, Mohammad Sadik, Subhan, Amna, Shakir, Tanzila, Jafri, Wasim, Hamid, Saeed
Format: Artigo
Jezik:Inglês
Izdano: Kowsar 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867024/
https://ncbi.nlm.nih.gov/pubmed/24358041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.14146
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items